Carrie Cox
Chairman at ORGANON & CO.
Net worth: 11 M $ as of 2024-03-30
Profile
Ms. Carrie S. Cox is a Chairman at Organon & Co., a Chairman at Advantagene, Inc., a Chairman at Selecta Biosciences, Inc., an Independent Director at Cardinal Health, Inc., an Independent Director at Texas Instruments Incorporated and a Member-Overseers Board at University of Pennsylvania Museum of Archaeology & Anthropolog. She is on the Board of Directors at Cardinal Health, Inc. and Texas Instruments Incorporated. Ms. Cox was previously employed as a Chairman by Array BioPharma, Inc., a Chairman by electroCore, Inc., an Independent Director by Celgene Corp., a President-Global Pharmaceuticals & Executive VP by Schering-Plough Corp., a Senior Vice President-Global Business Management by Pharmacia & Upjohn, Inc., a President-Global Prescription Business & EVP by Pharmacia Corp., a Member by Harvard T.H. Chan School of Public Health, a Principal by Novartis Corp., a Chairman by Prism Pharmaceuticals, Inc., and a Vice President-Women's Healthcare by Wyeth-Ayerst Research. She also served on the board at Humacyte, Inc. and Renetx Bio, Inc. She received her undergraduate degree from Massachusetts College of Pharmacy & Health Science.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-27 | 35,801 ( 0.00% ) | 6 M $ | 2024-03-30 | |
CARDINAL HEALTH, INC.
0.02% | 2023-09-17 | 41,631 ( 0.02% ) | 5 M $ | 2024-03-30 |
0.13% | 2024-01-14 | 212,881 ( 0.13% ) | 138 373 $ | 2024-03-30 |
ORGANON & CO.
-.--% | 2023-06-08 | 0 ( -.--% ) | - $ | 2024-03-30 |
Carrie Cox active positions
| Companies | Position | Start |
|---|---|---|
| TEXAS INSTRUMENTS INCORPORATED | Director/Board Member | 2004-09-15 |
| ORGANON & CO. | Chairman | 2021-06-01 |
| University of Pennsylvania Museum of Archaeology & Anthropolog | Corporate Officer/Principal | - |
Former positions of Carrie Cox
| Companies | Position | End |
|---|---|---|
| CARDINAL HEALTH, INC. | Director/Board Member | 2023-11-14 |
| HUMACYTE, INC. | Chief Executive Officer | 2018-05-31 |
| CANDEL THERAPEUTICS, INC. | Chairman | 2021-07-14 |
| ELECTROCORE, INC. | Chairman | 2020-03-30 |
| CELGENE | Director/Board Member | 2019-10-31 |
Training of Carrie Cox
| Massachusetts College of Pharmacy & Health Science | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| CARDINAL HEALTH, INC. | Distribution Services |
| TEXAS INSTRUMENTS INCORPORATED | Electronic Technology |
| ELECTROCORE, INC. | Health Technology |
| CANDEL THERAPEUTICS, INC. | Health Technology |
| ORGANON & CO. | Health Technology |
| HUMACYTE, INC. | Health Technology |
| Private companies | 12 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
| Pharmacia & Upjohn, Inc. | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Prism Pharmaceuticals, Inc.
 Prism Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Prism Pharmaceuticals, Inc. manufactures cardiovascular injectables and pharmaceutical products. The firm engages in developing and commercializing branded cardiovascular injectable products which include NEXTERONE. The company was founded by Gilbert R. Gonzales and Cameron Durrant in 2003 and is headquartered in King of Prussia, PA. | Health Technology |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Humacyte Global, Inc.
 Humacyte Global, Inc. Medical SpecialtiesHealth Technology Humacyte Global, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason, Juliana L. Blum and Shannon L. M. Dahl in 2004 and is headquartered in Durham, NC. | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
Renetx Bio, Inc.
 Renetx Bio, Inc. BiotechnologyHealth Technology Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT. | Health Technology |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ. | Health Technology |
| Wyeth-Ayerst Research | |
| University of Pennsylvania Museum of Archaeology & Anthropolog |
- Stock Market
- Insiders
- Carrie Cox
